News | Proton Therapy | October 27, 2015

IBA Announces Upgrades to Penn Medicine Proton Therapy Center Equipment

New advances include cone beam CT, pencil beam scanning technology

Penn Medicine, IBA upgrades, Roberts Proton Therapy Center, PBS, CBCT

October 27, 2015 — IBA announced that longtime customer and research partner Penn Medicine has upgraded the equipment of its Roberts Proton Therapy Center with the latest innovations in proton therapy treatment. This upgrade to the newest technologies will allow Penn Medicine’s staff to continue to offer top-level proton radiation therapy services to an increasing number of patients and to further advance the clinical application of proton therapy.

Penn Medicine treated its first proton patient in March 2010. Research collaborations with IBA are extensive, with Penn Medicine contributing to the research on pencil beam scanning (PBS) protocols and cone beam computed tomography (CBCT), among others. Penn Medicine’s proton therapy facility and experts also play a key role in IBA’s training program, sharing knowledge and experience to contribute to the education of the entire proton therapy community.

Recent acquisitions by the Roberts Proton Therapy Center include:

  • Having taken part in the development and optimization of IBA’s CBCT, Penn Medicine has opted to purchase this image guidance tool, which ensures increased accuracy in patient positioning and brings the center one step closer to adaptive proton therapy treatment;
  • Penn Medicine will replace one of its universal nozzles to a dedicated PBS nozzle. This brings Penn Medicine to a total of four PBS treatment rooms, with one double scattering treatment room remaining. It will allow Penn clinicians to offer the most accurate delivery of proton therapy currently available to a larger number of patients, while maintaining the advantage double scattering provides when treating moving targets. This adapted configuration provides Penn Medicine with the option to cover a very broad range of indications, with fixed as well as moving targets; and
  • For research purposes, Penn Medicine will also deploy the Universal Monitoring Interface (UMI) and Adapt Analytics software. These software applications are used to monitor how much time is spent on and by the patient at different treatment stages. The aim of this research is to improve the workflow efficiency in order to optimize throughput. Ultimately, it will allow more patients, at Penn Medicine and elsewhere, to benefit from proton therapy treatment.

The current Penn Medicine upgrade exceeds $3 million USD, and IBA still has a general pipeline left of $7 million.

James Metz, M.D., chair of Penn Medicine Department of Radiation Oncology, commented, “The clinical application of proton therapy is a medical field in full evolution. At Penn Medicine, we believe in its potential and are fully committed to helping its realization, leveraging topnotch technology to make sure that as many eligible patients as possible can benefit from this radiation therapy modality, now and in the future.”

For more information: www.iba-worldwide.com

Related Content

MERCK and RefleXion Medical announced a collaboration to evaluate KETRUDA (immunotherapy) with biology-guided radiotherapy - BgRT -  a new radiation machine developed to treat all stages of cancer.

MERCK and RefleXion Medical announced a collaboration to evaluate KETRUDA (immunotherapy) with biology-guided radiotherapy - BgRT -  a new radiation machine developed to treat all stages of cancer.

 

News | Radiation Therapy | June 01, 2020
June 1, 2020 — RefleXion Medical, a therape
Technology becomes a state-of-the-art tool when it gets exposed to a structure that constantly tests it and allows it to evolve.

Technology becomes a state-of-the-art tool when it gets exposed to a structure that constantly tests it and allows it to evolve. Getty Images

Feature | Oncology Information Management Systems (OIMS) | May 27, 2020 | By Reshu Gupta
In the history of medicine, researchers have found cures for many diseases, but cancer has been elusive.
Miami Cancer Institute’s Proton Therapy Center is the first in South Florida and the region’s top destination for this leading-edge treatment. Proton therapy is an advanced form of radiation therapy that uses pencil beam scanning (PBS) technology.

Miami Cancer Institute’s Proton Therapy Center is the first in South Florida and the region’s top destination for this leading-edge treatment. Proton therapy is an advanced form of radiation therapy that uses pencil beam scanning (PBS) technology.

Feature | Proton Therapy | May 27, 2020 | By Minesh Mehta, M.D.
Radiation therapy has advanced significantly in the last few decades as a result of a continued technological revolut
Despite facing challenges such as limited access to personal protective equipment (PPE) following the COVID-19 outbreak, radiation oncology clinics quickly implemented safety and process enhancements that allowed them to continue caring for cancer patients, according to a new national survey from the American Society for Radiation Oncology (ASTRO).

Getty Images

News | Coronavirus (COVID-19) | May 21, 2020
May 21, 2020 — Despite facing challenges such as limited access to...
The global radiation therapy market is expected to reach $10.11 billion in 2024, witnessing growth at a CAGR of 3.38%, over the period 2020-2024.
News | Proton Therapy | May 20, 2020
May 20, 2020 — ResearchAndMarkets.com has released its latest report, the ...
An innovative radiation treatment that could one day be a valuable addition to conventional radiation therapy for inoperable brain and spinal tumors is a step closer, thanks to new research led by University of Saskatchewan (USask) researchers at the Canadian Light Source (CLS).

USask PhD bio-medical engineering student Farley Chicilo at the Canadian Light Source synchrotron at University of Saskatchewan. Photo courtesy of Canadian Light Source, University of Saskatchewan

News | Radiation Therapy | May 14, 2020
May 14, 2020 — An innovative radiation treatment t
Medical University of South Carolina researchers have developed and validated prediction tools, known as nomograms, that could be used to help prevent delays in the initiation of radiotherapy after surgery for head and neck cancer

 

Evan Graboyes, M.D., and his team believe their nomogram tools will improve survival rates for head and neck cancer patients. Photo courtesy of MUSC Hollings Cancer Center

 

News | Radiation Oncology | May 14, 2020
May 14, 2020 — More than 65,000 Americans are diagnosed annually with head and neck cancer, which most often occurs i
Due to ongoing health concerns related to the spread of the Coronavirus (COVID-19) as well as global travel restrictions, the American Association of Physicists in Medicine (AAPM) has decided to evolve the Joint AAPM/COMP (Canadian Organization of Medical Physicists) Meeting content into a virtual (completely online) meeting in place of the in-person meeting originally scheduled for July 12-16, 2020, in Vancouver, BC.
News | AAPM | May 11, 2020
May 11, 2020 — Due to ongoing health concerns related to the spread of the Coronavirus (...